BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758
123 results:

  • 1. Triple Primary cancers: An Analysis of Genetic and Environmental Factors.
    Borja NA; Silva-Smith R; Calfa C; Sussman DA; Tekin M
    Cancer Prev Res (Phila); 2024 May; 17(5):209-215. PubMed ID: 38361103
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Nomograms confirm serum IL-6 and CRP as predictors of immune checkpoint inhibitor efficacy in unresectable hepatocellular carcinoma.
    Du J; Huang Z; Zhang E
    Front Immunol; 2024; 15():1329634. PubMed ID: 38304429
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Retrospective Analysis of the Impact of High- and Low-Quality Donor livers for Patients with High-Acuity Illness.
    Varghese RK; Handing GE; Montgomery AE; Rana AA; Goss JA
    Ann Transplant; 2024 Jan; 29():e941931. PubMed ID: 38192097
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Novel urine cell-free DNA methylation markers for hepatocellular carcinoma.
    Lin SY; Xia W; Kim AK; Chen D; Schleyer S; Choi L; Wang Z; Hamilton JP; Luu H; Hann HW; Chang TT; Hu CT; Woodard A; Gade TP; Su YH
    Sci Rep; 2023 Dec; 13(1):21585. PubMed ID: 38062093
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Increased risk of cancer and cancer-related mortality in middle-aged Korean women with prediabetes and diabetes: a population-based study.
    Tran TXM; Kim S; Song H; Park B
    Epidemiol Health; 2023; 45():e2023080. PubMed ID: 37654164
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation.
    Zhang S; Shi YN; Gu J; He P; Ai QD; Zhou XD; Wang W; Qin L
    Pharm Biol; 2023 Dec; 61(1):1108-1119. PubMed ID: 37462387
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Factors Influencing the Diagnostic Performance of Repeat Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy after the First Inconclusive Diagnosis of Pancreatic Solid Lesions.
    Cho JH; Kim J; Lee HS; Ryu SJ; Jang SI; Kim EJ; Kang H; Lee SS; Song TJ; Bang S
    Gut Liver; 2024 Jan; 18(1):184-191. PubMed ID: 37317559
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Stereotactic Body Radiation Therapy With or Without Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone in Early-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Dumago MP; Agas RAF; Jainar CJE; Yap ET; Co LBA; Ortin TTS
    J Gastrointest Cancer; 2023 Dec; 54(4):1058-1070. PubMed ID: 37306936
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrated network findings reveal ubiquitin-specific protease 44 overexpression suppresses tumorigenicity of liver cancer.
    Zhou H; Yang L; Lin X; Chan TF; Lee NP; Tse WKF; Zhang X; Li R; Lai KP
    Aging (Albany NY); 2023 May; 15(10):4304-4318. PubMed ID: 37204480
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Construction and validation of a nomogram for hepatocellular carcinoma patients treated by traditional Chinese medicine based on inflammation, nutrition, and blood lipid indicators.
    Yu X; Yang R; He Z; Zeng P
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8969-8979. PubMed ID: 37160627
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [The expression and function of PD-L1 in CD133(+) human liver cancer stem-like cells].
    Bai YD; Shi ML; Li SQ; Wang XL; Peng JJ; Zhou DJ; Sun FF; Li H; Wang C; Du M; Zhang T; Li D
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):117-128. PubMed ID: 36781232
    [No Abstract]    [Full Text] [Related]  

  • 12. Development and validation of a risk prediction model for incident liver cancer.
    Liu Y; Zhang J; Wang W; Li G
    Front Public Health; 2022; 10():955287. PubMed ID: 36568745
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study.
    Wang DD; Zhang JF; Zhang LH; Niu M; Jiang HJ; Jia FC; Feng ST
    Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):594-604. PubMed ID: 36456428
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Preoperative Predictive Nomogram Based on Alanine Aminotransferase, Prothrombin Time Activity, and Remnant liver Proportion (APART Score) to Predict Post-Hepatectomy liver Failure after Major Hepatectomy.
    Maehira H; Iida H; Mori H; Nitta N; Maekawa T; Takebayashi K; Kaida S; Miyake T; Tani M
    Eur Surg Res; 2023; 64(2):220-229. PubMed ID: 36380617
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Deubiquitinating Enzyme USP4 Functions as an Oncoprotein in Gastric cancer and Mediates NF-κB Signaling by Regulating PRL-3 Expression.
    Tao Y; You W
    Front Biosci (Landmark Ed); 2022 Oct; 27(10):286. PubMed ID: 36336860
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Timing of Organ Procurement From Brain-Dead Donors Associates With Short- and Long-Term Outcomes After liver Transplantation.
    Eerola V; Helanterä I; Åberg F; Lempinen M; Mäkisalo H; Nordin A; Isoniemi H; Sallinen V
    Transpl Int; 2022; 35():10364. PubMed ID: 36118016
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Circular Noncoding RNA hsa_circ_0003570 as a Prognostic Biomarker for Hepatocellular Carcinoma.
    Jang SY; Kim G; Tak WY; Kweon YO; Lee YR; Han YS; Han JR; Park JG; Kang MK; Lee HW; Lee WK; Park SY; Hur K
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011395
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Influencing factors related to transcatheter arterial chemoembolization for hepatocellular carcinoma patients achieved tumor response.
    Shao H; Deng J; Xie L; Zheng Q; Zou B; Deng J; Zhang T; He J
    J Cancer Res Ther; 2022 Apr; 18(2):560-566. PubMed ID: 35645128
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Detection of hepatocellular carcinoma in a population at risk: iodine-enhanced multidetector CT and/or gadoxetic acid-enhanced 3.0 T MRI.
    Qiong L; Jie Z; Zhong Z; Wen S; Jun Z; Liping L; Jinkui C
    BMJ Open; 2022 Feb; 12(2):e058461. PubMed ID: 35177466
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Risk of infections and their role on subsequent mortality in biopsy-proven alcohol-related liver disease.
    Hagström H; Thiele M; Simon TG; Sharma R; Röckert Tjernberg A; Roelstraete B; Söderling J; Ludvigsson JF
    United European Gastroenterol J; 2022 Mar; 10(2):198-211. PubMed ID: 35088575
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.